Windtree Therapeutics Stock Market Value
| WINT Stock | USD 0.01 0 29.58% |
| Symbol | Windtree |
Is there potential for Biotechnology market expansion? Will Windtree introduce new products? Factors like these will boost the valuation of Windtree Therapeutics. Anticipated expansion of Windtree directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Windtree Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Windtree Therapeutics requires distinguishing between market price and book value, where the latter reflects Windtree's accounting equity. The concept of intrinsic value - what Windtree Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Windtree Therapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Windtree Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Windtree Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Windtree Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Windtree Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Windtree Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Windtree Therapeutics.
| 11/06/2025 |
| 02/04/2026 |
If you would invest 0.00 in Windtree Therapeutics on November 6, 2025 and sell it all today you would earn a total of 0.00 from holding Windtree Therapeutics or generate 0.0% return on investment in Windtree Therapeutics over 90 days. Windtree Therapeutics is related to or competes with Revelation Biosciences, Dermata Therapeutics, Avenue Therapeutics, XORTX Therapeutics, Virax Biolabs, Ainos, and NewcelX. Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for ... More
Windtree Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Windtree Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Windtree Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.24) | |||
| Maximum Drawdown | 58.33 | |||
| Value At Risk | (20.00) | |||
| Potential Upside | 16.67 |
Windtree Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Windtree Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Windtree Therapeutics' standard deviation. In reality, there are many statistical measures that can use Windtree Therapeutics historical prices to predict the future Windtree Therapeutics' volatility.| Risk Adjusted Performance | (0.16) | |||
| Jensen Alpha | (2.44) | |||
| Total Risk Alpha | (2.97) | |||
| Treynor Ratio | (1.54) |
Windtree Therapeutics February 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.16) | |||
| Market Risk Adjusted Performance | (1.53) | |||
| Mean Deviation | 6.63 | |||
| Coefficient Of Variation | (429.12) | |||
| Standard Deviation | 10.15 | |||
| Variance | 102.96 | |||
| Information Ratio | (0.24) | |||
| Jensen Alpha | (2.44) | |||
| Total Risk Alpha | (2.97) | |||
| Treynor Ratio | (1.54) | |||
| Maximum Drawdown | 58.33 | |||
| Value At Risk | (20.00) | |||
| Potential Upside | 16.67 | |||
| Skewness | (0.48) | |||
| Kurtosis | 2.18 |
Windtree Therapeutics Backtested Returns
Windtree Therapeutics shows Sharpe Ratio of -0.23, which attests that the company had a -0.23 % return per unit of risk over the last 3 months. Windtree Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Windtree Therapeutics' Market Risk Adjusted Performance of (1.53), mean deviation of 6.63, and Standard Deviation of 10.15 to validate the risk estimate we provide. The firm maintains a market beta of 1.54, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Windtree Therapeutics will likely underperform. At this point, Windtree Therapeutics has a negative expected return of -2.49%. Please make sure to check out Windtree Therapeutics' jensen alpha and rate of daily change , to decide if Windtree Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.71 |
Good predictability
Windtree Therapeutics has good predictability. Overlapping area represents the amount of predictability between Windtree Therapeutics time series from 6th of November 2025 to 21st of December 2025 and 21st of December 2025 to 4th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Windtree Therapeutics price movement. The serial correlation of 0.71 indicates that around 71.0% of current Windtree Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.71 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Windtree Stock Analysis
When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.